A recent study indicates that people who discontinue new slimming jabs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.
Findings released in a leading medical journal points out that while overweight people often shed about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing these medications must be cognizant of the potential of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment weight in about one and a half years.
Weighing Therapies
The analysis, which reviewed dozens of trials involving thousands of participants, compared the effects of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who lose weight through lifestyle changes alone usually have a more gradual weight regain—around 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Doctors propose the mechanism of the drugs accounts for the heightened regain.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 levels several times higher than normal may cause the body to produce less of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement results in appetite is unsuppressed, making binge eating far more likely."
An Ongoing Disease?
Medical guidelines advise the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, due to the significant potential of relapse, the therapy should be considered ongoing.
This perspective is reinforced by pharmaceutical companies, who say that the results "underscore the long-term character of obesity," similar to managing diseases like hypertension.
User Testimonies
Individuals who have come off the medication explain a intense resurgence of appetite.
"It felt as if a switch that goes on and you become extremely hungry," said a patient.
This difficulty is worsened if individuals have not developed permanent dietary or behavioural modifications during therapy.
Widespread Interest
Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with desire continuing to grow.
- Adoption is greater among females than men.
- The middle-aged age group shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
Ultimately, researchers stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent solution and maintained weight loss likely depends on combined lifestyle management.
